Abstract:Background: Topical photodynamic therapy (PDT) mediated with 5-aminolevulinic acid (ALA) offers an alternative option for the treatment of acne vulgaris. Objective: To study the effects of ALA dose, incubation time, and lesion type on protoporphyrin IX (PpIX) production and treatment outcomes. Methods: To examine the time course of PpIX production, 10% ALA was applied to inflammatory papules for 1 to 5 hours and followed by in situ fluorescence examination. To determine the effects of ALA dose and lesion type, 3, 5, and 10% ALA was applied to acne lesions in split-face fashion for 3 hours followed by whole-face light irradiation at 633 nm and 30 to 70 J/cm2. Treatment was repeated twice at 2-week intervals. Results: PpIX reached a stable level after 3 hours of incubation. Similar PpIX levels were seen in areas receiving 3, 5, and 10% ALA. Poisson regression analyses indicated that lesion counts decreased by 0.791 times for a one-unit increase in treatment times (95% CI 0.782–0.799, p< .0001) but only by 0.999 times for a one-unit increase in ALA dose (95% CI 0.998–1.000, p = .22). Conclusion: The combination of low-dose ALA and a red light is a safe and effective option for the treatment of moderate to severe acne. Renseignements de base: La thérapie photodynamique topique (TPD) suivant l'administration de l'acide 5-aminolévulinique (ALA) représente une autre possibilité pour le traitement de l'acné vulgaire. Objectif: Étudier les effets de la dose d'ALA, la durée d'incubation, le type de lésion sur la production de PpIX, et les résultats du traitement. Méthodes: Pour examiner l'évolution temporelle de la production de PpIX, de l'ALA 10 % a été appliqué sur des papules inflammatoires pendant 1 à 5 heures et a été suivi d'un examen in situ en fluorescence. Afin de déterminer les effets de la dose d'ALA et le type de lésion, de l'ALA 3, 5, et 10 % a été appliqué sur les lésions d'acné sur une moitié du visage pendant 3 heures, suivi d'une irradiation de lumière de tout le visage à 633 nm et 30 à 70 J/cm2. Le traitement a été répété deux fois à 2 semaines d'intervalle. Résultats: La PpIX a atteint un niveau stable après 3 heures d'incubation. Des taux de PpIX semblables ont été observés dans les parties ayant reçu de l'ALA 3, 5, et 10 %. Des analyses de régression de Poisson ont indiqué que le nombre de lésions a diminué de 0,791 fois pour une augmentation d'une unité de temps de traitement (IC 95 % 0,782 à 0,799, p <,0001), mais seulement par 0,999 fois pour un accroissement d'une unité de dose d'ALA (CI 95 % 0,998 à 1,000, p =, 22). Conclusion: La combinaison d'une faible dose d'ALA et de la lumière rouge est une option sûre et efficace pour traiter l'acné modérée à sévère.

ALA-PDT&nbsp;Amplifies Intense Inflammatory Response in the Treatment of Acne Vulgaris via CXCL8

5‐Aminolaevulinic acid photodynamic therapy amplifies intense inflammatory response in the treatment of acne vulgaris via CXCL8

ALA-PDT augments intense inflammation in the treatment of acne vulgaris by COX2/TREM1 mediated M1 macrophage polarization

ALA-PDT promotes IL-1β secretion from human SZ95 sebocytes via activation of the NLRP3 inflammasome

5-Aminolaevulinic acid photodynamic therapy suppresses lipid secretion of primary sebocytes through AMPK/SREBP-1 pathway

5-Aminolaevulinic acid-based photodynamic therapy suppresses lipid secretion by inducing mitochondrial stress and oxidative damage in sebocytes and ameliorates ear acne in mice

Topical Application Of Ala Pdt For The Treatment Of Moderate To Severe Acne Vulgaris

5-aminolevulinic acid photodynamic therapy using 560-1200 nm followed by 420-1200 nm broadband light in the treatment of moderate-to-severe acne

A Prospective Study of Adverse Reactions of ALA-PDT for Acne Vulgaris

Prospective Study of Topical 5-Aminolevulinic Acid Photodynamic Therapy for the Treatment of Moderate to Severe Acne Vulgaris in Chinese Patients

Topical aminolevulinic acid-photodynamic therapy in acne

Low-dose Topical 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Different Severity of Acne Vulgaris.

Therapeutic effect and follow-up analysis of photodynamic therapy in the treatment of moderate to severe acne

Analysis of Efficacy and Safety of 5-Aminolevulinic Acid-Mediated Photodynamic Therapy in the Treatment of ;Moderate to Severe Acne

Efficacy of 3.6% Topical ALA-PDT for the Treatment of Severe Acne Vulgaris.

Topical 5-Aminolevulinic Photodynamic Therapy with Red Light Vs Intense Pulsed Light for the Treatment of Acne Vulgaris: A Spilit Face, Randomized, Prospective Study

Ionic Liquid Pretreatment Enhances Skin Penetration of 5-Aminolevulinic Acid: A Promising Scheme for Photodynamic Therapy for Acne Vulgaris

A New LED Device Used for Photodynamic Therapy in Treatment of Moderate to Severe Acne Vulgaris

Efficacy and Therapeutic Reactions of Tri-Needle-pretreatment Combined with Painless ALA-PDT for the Treatment of Moderate-to-severe Acne Vulgaris: a Randomized Controlled Trial

Preliminary study of low-dose photodynamic therapy on the oxidative stress response of Cutibacterium acnes

Expert consensus on the clinical application of aminolevulinic acid-based photodynamic therapy for acne vulgaris (2022)#

ALA-PDT&amp;nbsp;Amplifies Intense Inflammatory Response in the Treatment of Acne Vulgaris via CXCL8